Ping Wu
About
In The Last Decade
Ping Wu
498 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Materials Chemistry 9.2k
- Electrical and Electronic Engineering 5.3k
- Electronic, Optical and Magnetic Materials 2.6k
- Biomedical Engineering 2.0k
- Mechanical Engineering 1.8k
Countries citing papers authored by Ping Wu
This map shows the geographic impact of Ping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wu more than expected).
Fields of papers citing papers by Ping Wu
This network shows the impact of papers produced by Ping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wu. The network helps show where Ping Wu may publish in the future.
Co-authorship network of co-authors of Ping Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Ping Wu. A scholar is included among the top collaborators of Ping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Wu. Ping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 11 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 19 | |
| 15 | Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review | 1 |
| 16 | Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo | 0 |
| 17 | Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation | 1 |
| 18 | 6 | |
| 19 | 29 | |
| 20 | Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomaterial | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.